LC-IMS-HRMS for identification of biomarkers in untargeted metabolomics: The effects of pterostilbene and resveratrol consumption in liver steatosis, animal model
![Thumbnail](/xmlui/bitstream/handle/10234/202242/84021.pdf.jpg?sequence=5&isAllowed=y)
Visualitza/
Impacte
![Google Scholar](/xmlui/themes/Mirage2/images/uji/logo_google.png)
![Microsoft Academico](/xmlui/themes/Mirage2/images/uji/logo_microsoft.png)
Metadades
Mostra el registre complet de l'elementcomunitat-uji-handle:10234/9
comunitat-uji-handle2:10234/33596
comunitat-uji-handle3:10234/33597
comunitat-uji-handle4:
INVESTIGACIONMetadades
Títol
LC-IMS-HRMS for identification of biomarkers in untargeted metabolomics: The effects of pterostilbene and resveratrol consumption in liver steatosis, animal modelAutoria
Data de publicació
2023Editor
ElsevierISSN
0963-9969Cita bibliogràfica
Lacalle-Bergeron L, Izquierdo-Sandoval D, Fernández-Quintela A, Portillo MP, Sancho JV, Hernández F, Portolés T. LC-IMS-HRMS for identification of biomarkers in untargeted metabolomics: The effects of pterostilbene and resveratrol consumption in liver steatosis, animal model. Food Res Int. 2023 Mar;165:112376. doi: 10.1016/j.foodres.2022.112376. Epub 2023 Jan 2. PMID: 36869462.Tipus de document
info:eu-repo/semantics/articleVersió
info:eu-repo/semantics/acceptedVersionParaules clau / Matèries
Resum
Untargeted metabolomics with the combination of ion mobility separation coupled to high resolution mass spectrometry (IMS-HRMS) was applied to investigate the impact of resveratrol and pterostilbene supplementation ... [+]
Untargeted metabolomics with the combination of ion mobility separation coupled to high resolution mass spectrometry (IMS-HRMS) was applied to investigate the impact of resveratrol and pterostilbene supplementation on the metabolic fingerprint of the Wistar rats liver with induced liver steatosis. RP-LC and HILIC in both ionisation modes were employed to analyse the liver samples (n = 40) from Wistar rats fed with a high-fat and high-fructose diet, supplemented or not with resveratrol and pterostilbene. After univariate and multivariate statistical analysis, 34 metabolites were highlighted in the different diets and elucidated. Despite the structural similarity, different alterations in liver metabolism were observed by the supplementations. Resveratrol treatment was characterised by the alteration in metabolism of 17 lysophospholipids, while pterostilbene affected some vitamins and derivatives, among others. IMS has demonstrated great potential in the elucidation process thanks to the additional structural descriptor the CCS (Å2), providing more confidence in the identification. [-]
Publicat a
Food Research International. 2023 Mar;165:112376Entitat finançadora
Universitat Jaume I | Ministry of Science , Innovation and Universities of Spain | Ministry of Economy and Competitiveness, Spain | Generalitat Valenciana | University of the Basque Country | Ministerio de Economía y Competitividad-Fondo Europeo de Desarrollo Regional | CIBERobn
Codi del projecte o subvenció
UJI 19I001 /03 | FPU19 / 01839 | RYC -2017 -22525 | PROMETEO/2019 /040 | UJI-B2020-25 | UJI-B2020-37 | GIU 18 /173 | AGL-2015-6571 9-R MINECO /FEDER, UE | CB12/03/30007
Drets d'accés
© 2023 Elsevier Ltd. All rights reserved
info:eu-repo/semantics/openAccess
info:eu-repo/semantics/openAccess
Apareix a les col.leccions
- IUPA_Articles [309]